SeaStar Medical Holding Corporation (ICUCW)Denver, United States | NasdaqCM
0.02 USD
+0.00
(1.734%)
⇧
(Aug. 28, 2026, 3:26 p.m.
EDT)
|
Hot Take ↕ | Aug. 22, 2026, 4:50 a.m. EDT
The security is trading at a fraction of its book value due to catastrophic operational performance, making it a dangerous speculative vehicle rather than an investment. Despite reporting an impressive 82% revenue growth, the company is burning cash aggressively with negative operating cash flow and a return on equity of nearly -360%, indicating that the top-line expansion is not translating into profitability or value creation. The balance sheet shows significant leverage relative to equity, and the recent price action is characterized by volatility and thin trading volume, with headlines suggesting 'fade trades' and 'put walls' rather than sustainable accumulation. With no dividend history and a complete lack of price trajectory data to assess long-term market validation, the business fundamentals are deteriorating rapidly despite the revenue headline. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 3.119 |
| Revenue per Share | 0.479 |
| Beta | -1.04 |
| Previous Name | LMF Acquisition Opportunities, Inc. |
| Website | https://seastarmedical.com |
| Attribute | Value |
|---|---|
| Address1 | 3,513 Brighton Boulevard |
| Address2 | Suite 410 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | -1.037 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 1.008 |
| City | Denver |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.0176 |
| Current Ratio | 1.89 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.0185 |
| Day Low | 0.0149 |
| Debt To Equity | 3.119 |
| Display Name | SeaStar Medical Holding |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.0185 |
| Fifty Two Week High Change | -0.00090000033 |
| Fifty Two Week High Change Percent | -0.048648667 |
| Fifty Two Week Low | 0.0149 |
| Fifty Two Week Low Change | 0.0027 |
| Fifty Two Week Low Change Percent | 0.18120806 |
| Fifty Two Week Range | 0.0149 - 0.0185 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,784,295,000,000 |
| Float Shares | 4,360,878 |
| Free Cashflow | -9,141,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 18 |
| Fullday Change | 0.0002999995 |
| Fullday Change Percent | 1.734101 |
| Fullday Price | 0.0176 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.92644 |
| Gross Profits | 1,587,000 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Language | en-US |
| Long Business Summary | SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado. |
| Long Name | SeaStar Medical Holding Corporation |
| Market | us_market |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_111447 |
| Name Change Date | 2,026-08-28 |
| Net Income To Common | -13,627,000 |
| Open | 0.0375 |
| Operating Cashflow | -13,693,000 |
| Operating Margins | -6.16423 |
| Phone | 844 427 8100 |
| Prev Name | LMF Acquisition Opportunities, Inc. |
| Previous Close | 0.0173 |
| Price Hint | 4 |
| Price To Book | 0.017460316 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.646 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0002999995 |
| Regular Market Change Percent | 1.734101 |
| Regular Market Day High | 0.0185 |
| Regular Market Day Low | 0.0149 |
| Regular Market Day Range | 0.0149 - 0.0185 |
| Regular Market Open | 0.0375 |
| Regular Market Previous Close | 0.0173 |
| Regular Market Price | 0.0176 |
| Regular Market Time | 1,787,945,211 |
| Regular Market Volume | 84,324 |
| Return On Assets | -1.02667 |
| Return On Equity | -3.56868 |
| Revenue Growth | 0.82 |
| Revenue Per Share | 0.479 |
| Sand P52 Week Change | 0.1966995 |
| Sector | |
| Sector Key | |
| Source Interval | 15 |
| State | CO |
| Symbol | ICUCW |
| Total Cash | 6,959,000 |
| Total Cash Per Share | 1.579 |
| Total Debt | 134,000 |
| Total Revenue | 1,713,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 84,324 |
| Website | https://seastarmedical.com |
| Zip | 80,216 |